Skip to main content
. 2021 Apr 21;271(5):915–927. doi: 10.1007/s00406-021-01259-7

Fig. 1.

Fig. 1

CONSORT diagram of subject flow through the study. Datasets of n = 44 patients (n = 22 of whom later received Naltrexone [NTX] in addition to intensified withdrawal treatment [IWT]) with complete baseline imaging data and complete follow-up data were included in current analyses. Datasets of other patients with incomplete baseline fMRI data or incomplete follow-up data and datasets of the healthy control sample were not included in current analyses. These data are reported in Bach et al. [6]